| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| checkmate 577 | 1.06 | 0.6 | 5640 | 80 | 13 |
| checkmate | 1.74 | 0.5 | 7459 | 98 | 9 |
| 577 | 1.55 | 0.7 | 5784 | 60 | 3 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| checkmate 577 | 1.54 | 0.8 | 9116 | 4 |
| checkmate 577 trial | 0.57 | 0.9 | 7888 | 58 |
| checkmate 577 nivolumab | 0.58 | 0.1 | 2927 | 58 |
| checkmate 577 update | 1.38 | 0.1 | 730 | 27 |
| checkmate 577 nejm | 1.32 | 0.1 | 723 | 74 |
| checkmate 577 overall survival | 1.76 | 0.9 | 8688 | 64 |
| checkmate 577 trial design | 1.3 | 0.7 | 910 | 6 |
| checkmate 577 study | 0.73 | 0.8 | 2417 | 72 |
| checkmate 577 pfs | 1.27 | 1 | 5074 | 15 |
| checkmate 577 kelly | 0.86 | 0.7 | 3323 | 34 |
| checkmate 577 pubmed | 0.76 | 0.2 | 9960 | 10 |
| checkmate 577 approval | 1.91 | 0.7 | 4778 | 46 |
| checkmate 577 clinical trial | 1.28 | 0.5 | 6024 | 70 |
